This year’s forums will be hybrid, allowing for greater global exposure, while allowing us to meet in-person. We look forward to welcoming you virtually or in-person in Amsterdam.
Follow us on our social channels for the latest updates.
The Ophthalmology Futures Retina Forum 2023 covers several key topics, including the use of dual mechanism anti-VEGF therapies, the role of AI and digital health, gene therapy for retinal diseases, sustained delivery for anti-VEGF therapy, and novel therapies for geographic atrophy. The Forum also explores the impact of global regulatory processes on retinal disease and therapy.
The discussions and insights generated from the forum have the potential to shape the future of retinal disease management.
>> Click here to download the PDF programme
Registration
Welcome
Panel 1: Dual Mechanism Anti-VEGF Therapies vs Novel Formulations of Older Agents: Will Patients & Providers have a Preference?
Co-chairs
Francesco Bandello
Robyn Guymer
Panellists
Gemmy Cheung
Grégoire Schwach
Nancy Holecamp
Stephen Poor
Surendra Sharma
Panel 2: Can AI & Digital Health Accelerate the Execution or Reduce the Cost of Clinical Trials?
Co-chairs
Adnan Tufail
Ursula Schmidt-Erfurth
Panellists
Andrzej Grzybowski
Cynthia Toth
Dawn Sim
Kester Nahen
Stephane Wolf
Stephanie Magazzeni
Networking Break
Panel 3: Novel Instrumentation for Back of the Eye Diseases: Who Will Continue to Invest?
Chair
Panellists
Eugene de Juan
Karlheinz Rein
Lionel Jouet
Marc de Smet
Paul Hallen
Panel 4: Visual Preservation in Retinal Diseases: Will Gene Therapy Make a Dent?
Chair
Panellists
Andreas Clemens
Francine Behar-Cohen
Nadia Waheed
Ramin Valian
Robert Kim
Samarendra Mohanty
Victor Chong
Networking Lunch
Sponsored by
Company Presentations 1
- Notal Vision
Kester Nahen | CEO - Eyecheckup
Rim Khazhin | CTO - Deepeye Medical
Ratko Petrovic | CTO - Photoprotective Technology
James Gallas | Director, New Business Development - Endogena Therapeutics
Matthias Steger | CEO - Beacon Therapeutics
Darin Curtiss | VP of Clinical Development - Nanoscope Therapeutics
Samarendra Mohanty | President & CSO - AAVantegarde Bio
Natalia Misciattelli | Head of Corp Development - Eyevensys
Francine Behar Cohen | CEO & President - REGENXBIO
Sumie Takahara | Director, Global Product & Market Planning
Investment Perspective
Panel 5: Investment in Back of the Eye Products: Is it Safer than Buying Cryptocurrency?
Chair
Panellists
Christina Takke
Daniela Couto
Elisa Petris
Klaus Stöekemann
Limin Wang
Rusty Kelley
Panel 6: Sustained Delivery for Anti-VEGF Therapy: Come & Gone, or Still in Play?
Chair
Panellists
Christopher Brittain
Jason Ehrlich
Melissa Liew
Michael O’Rourke
Michael Singer
Riad Sherif
Networking Break
Company Presentations 2
- Re-Vana Therapeutics
Michael O’Rourke | CEO - Tarsier Pharma
Daphne Haim Langford | CEO - Oculis
Riad Sherif | CEO - Aldropika Therapeutics
Uttam Surana | CSO - Ocuterra Therapeutics
Kerrie Brady | CEO & President - Outlook Therapeutics
Surendra Sharma | SVP-Medical Affairs - Kuria Therapeutics
Keith Ward | CEO - Complement Therapeutics
Rafiq Hasan | CEO - Aviceda Therapeutics
Tarek Hassan | Chief Development Office - Apellis Pharmaceuticals
Lukas Scheibler | Chief Research Officer - Iveric Bio, An Astellas Company
Erin Henry | VP, Product, Strategy & Innovation
Panel 7: Global Harmonization of Regulatory Processes for Drugs & Biologics: The Impact on Retinal Disease & Therapy
Chair
Panellists
Panel 8: Novel Therapies for Geographic Atrophy: How do we Measure Success for Physicians, Patients & Payers?
Co-chairs
Usha Chakravarthy
Einar Stefánsson
Panellists
Art Ciociola
Caroline Baumal
Erin Henry
Mohamed Genead
Rafiq Hasan
Sobha Sivaprasad
Summary
Concluding Comments
Reception
Our Ophthalmology Futures Forums are clinician-driven innovation meetings focusing on new technology, entrepreneurial ventures, market access, and other aspects of commercialisation in the ophthalmic healthcare sector.
They cover all aspects of global innovation in ophthalmic devices, diagnostics, and pharmaceuticals by connecting scientists, physicians, regulators, reimbursement specialists, corporate leaders, venture capitalists, and other investors who support the advancement of eye care.
Sponsorship Opportunities
Our forum sponsorship opportunities offer organisations of all sizes a unique platform to promote their organisation, products, and services to prominent business and scientific leaders.
If your organisation would be interested in presenting at one of our Forums, please submit your application via the Apply to Present page.
Sponsorship opportunities are available for our European, Asian and Retina Forums or special rates are available for combined sponsorship. Please contact us for further information or for a sponsorship prospectus.